1-s2.0-S2405803315000205-main.pdf?_tid=...17960_115f4762062987c4ffa3fc16f0361cb7

First Page		Document Content
Date: 2016-02-23 14:37:07 Oncology RTT Induced stem cells Tumor Tumor microenvironment Carcinogenesis Cellular differentiation Metastasis Cancer Neoplasm Treatment of cancer Breast cancer		1-s2.0-S2405803315000205-main.pdf?_tid=...17960_115f4762062987c4ffa3fc16f0361cb7 Add to Reading List Source URL: www2.lbl.gov Download Document from Source Website File Size: 483,55 KB Share Document on Facebook

	#4503 A Small Molecule Glycomimetic Antagonist of E-selectin (GMIPrevents Pancreatic Tumor Metastasis and Offers Improved Efficacy of Chemotherapy Maria M. Steele1, BS, Prakash Radhakrishnan1, PhD, John L. Magnani DocID: 1vkKU - View Document
	Quantitative image-based phenotypes for cancer metastasis systems biology Joel S. Bader, Ph.D. Professor, Biomedical Engineering Johns Hopkins University DocID: 1vd8y - View Document
	A small molecule glycomime.c antagonist of E-‐selec.n and CXCR4 (GMI-‐1359) delays pancrea.c tumor metastasis and signiﬁcantly alters the DocID: 1uubq - View Document
	Why we focus on Metastasis & Invasion Around 90% of cancer deaths are attributable to invasion and metastasis. Metastasis is the spread of disease from one organ or part to another not directly connected with the primary DocID: 1sjoH - View Document
	Nota de Prensa LA FDA APRUEBA DENOSUMAB PARA LA PREVENCIÓN DE EVENTOS ESQUELÉTICOS EN PACIENTES CON METÁSTASIS ÓSEAS DE TUMORES SÓLIDOS BARCELONA. (nov. 19, 2010) – La FDA ha aprobado denosumab, el primer y DocID: 1s5nh - View Document